1. Binnerts ME, van Kooyk Y, Edwards CP, Champe M, Presta L,
Bodary SC, Figdor CG, Berman PW. Antibodies that selectively inhibit leukocyte
function-associated antigen 1 binding to intercellular adhesion
molecule-3 recognize a unique epitope within the CD11a I
domain. J Biol Chem, 1996. 271(17):
9962-8.
2. van de Stolpe A, Jacobs N, Hage WJ, Tertoolen L, van Kooyk Y,
Novakova IR, de Witte T. Fibrinogen binding to ICAM-1 on EA.hy 926
endothelial cells is dependent on an intact cytoskeleton.
Thromb Haemost, 1996. 75(1): 182-9.
3. Buysmann S, Bemelman FJ, Schellekens PT, van Kooyk Y, Figdor
CG, ten Berge IJ. Activation and increased expression of adhesion
molecules on peripheral blood lymphocytes is a mechanism for the
immediate lymphocytopenia after administration of OKT3.
Blood, 1996. 87(1): 404-11.
4. van Kooyk Y, Binnerts ME, Edwards CP, Champe M, Berman PW,
Figdor CG, Bodary SC. Critical amino acids in the lymphocyte
function-associated antigen-1 I domain mediate intercellular
adhesion molecule 3 binding and immune function. J Exp
Med, 1996. 183(3): 1247-52.
5. Lub M, van Kooyk Y, Figdor CG. Competition between lymphocyte function-associated
antigen 1 (CD11a/CD18) and Mac-1 (CD11b/CD18) for binding to
intercellular adhesion molecule-1 (CD54). J Leukoc
Biol, 1996. 59(5): 648-55.
6. Adema GJ, Bakker AB, de Boer AJ, Hohenstein P, Figdor CG. pMel17 is recognised by monoclonal antibodies
NKI-beteb, HMB-45 and HMB-50 and by anti-melanoma CTL.
Br J Cancer, 1996. 73(9): 1044-8.
7. Torensma R, Raymakers RA, van Kooyk Y, Figdor CG. Induction of LFA-1 on pluripotent CD34+ bone
marrow cells does not affect lineage commitment.
Blood, 1996. 87(10): 4120-8.
8. Marland G, Bakker AB, Adema GJ, Figdor CG. Dendritic cells in immune response induction.
Stem Cells, 1996. 14(5): 501-7.